Risk factors for post‐thrombotic syndrome in patients with a first deep venous thrombosisLidwine W. Tick, Carine J.M. Doggen, Mark H.H. Kramer et al.|Journal of Thrombosis and Haemostasis|2008Cited by 224
Predictors of the post‐thrombotic syndrome with non‐invasive venous examinations in patients 6 weeks after a first episode of deep vein thrombosisLidwine W. Tick, Mark H.H. Kramer, Carine J.M. Doggen et al.|Journal of Thrombosis and Haemostasis|2010Cited by 86
Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trialMartine E.D. Chamuleau, Marie José Kersten, Joost S.P. Vermaat et al.|Haematologica|2019Cited by 53
Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLLLina van der Straten, Mark‐David Levin, Claudia A.M. Stege et al.|Blood|2023Cited by 27